Form D · Pharmaceuticals
VELIUS, LLC
Great Neck, NY · CIK 0001608403
Offering snapshot reported May 16, 2014 · SEC filing
- Reported sold
- Yet to sell Offering amount: $7M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 16, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-217563
Source: Form D, filed May 16, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Edward Dunn | Executive |
| Thomas Joseph Jennings | Director |
| William Alan Landman | Director |
| Peter Yarnton Mills | Executive |
| Andrew Bart Oxenhorn | Director |
| Lester Rosenkrantz | Director |
| Joel Roy Studin | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
15 Barstow Road
Great Neck, NY, 11021
Great Neck, NY, 11021